Product Description: IRAK inhibitor 1 is a potent IRAK-4 inhibitor with IC50 of 216 nM, is poorly active against JNK-1 and JNK-2 with IC50 of 3.801 μM, and >10 μM, respectively.
Applications: COVID-19-immunoregulation
Formula: C17H19N5
References: [1]Buckley GM, et al. IRAK-4 inhibitors. Part II: A structure-based assessment of imidazo[1,2-a]pyridine binding. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3291-5./[2]Li S, et al. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5567-72.
CAS Number: 1042224-63-4
Molecular Weight: 293.37
Compound Purity: 99.83
Research Area: Inflammation/Immunology
Solubility: DMSO : 16.67 mg/mL (ultrasonic)
Target: IRAK